NO20042844L - 4-(piperidyl- og pyrrolidyl-alkyl-ureido)-kinoliner som uprotensin II reseptor-antagonister - Google Patents
4-(piperidyl- og pyrrolidyl-alkyl-ureido)-kinoliner som uprotensin II reseptor-antagonisterInfo
- Publication number
- NO20042844L NO20042844L NO20042844A NO20042844A NO20042844L NO 20042844 L NO20042844 L NO 20042844L NO 20042844 A NO20042844 A NO 20042844A NO 20042844 A NO20042844 A NO 20042844A NO 20042844 L NO20042844 L NO 20042844L
- Authority
- NO
- Norway
- Prior art keywords
- uprotensin
- quinolines
- pyrrolidyl
- ureido
- piperidyl
- Prior art date
Links
- 229940111121 antirheumatic drug quinolines Drugs 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000002644 neurohormonal effect Effects 0.000 abstract 1
- ICJVRPQWEPOSOL-UHFFFAOYSA-N pyridin-4-ylurea Chemical class NC(=O)NC1=CC=NC=C1 ICJVRPQWEPOSOL-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP0114195 | 2001-12-04 | ||
| PCT/EP2002/013577 WO2003048154A1 (en) | 2001-12-04 | 2002-12-02 | 4-(piperidyl- and pyrrolidyl-alkyl-ureido) -quinolines as urotensin ii receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20042844L true NO20042844L (no) | 2004-08-23 |
Family
ID=8164711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20042844A NO20042844L (no) | 2001-12-04 | 2004-07-05 | 4-(piperidyl- og pyrrolidyl-alkyl-ureido)-kinoliner som uprotensin II reseptor-antagonister |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7375227B2 (de) |
| EP (1) | EP1499607B1 (de) |
| CN (1) | CN100424082C (de) |
| AT (1) | ATE312090T1 (de) |
| AU (1) | AU2002358071B2 (de) |
| CA (1) | CA2473892C (de) |
| CY (1) | CY1104993T1 (de) |
| DE (1) | DE60207894T2 (de) |
| DK (1) | DK1499607T3 (de) |
| ES (1) | ES2254772T3 (de) |
| HU (1) | HUP0402184A2 (de) |
| IL (1) | IL162851A0 (de) |
| MX (1) | MXPA04006599A (de) |
| NO (1) | NO20042844L (de) |
| NZ (1) | NZ534046A (de) |
| SI (1) | SI1499607T1 (de) |
| WO (1) | WO2003048154A1 (de) |
| ZA (1) | ZA200405348B (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2005111589A (ru) * | 2002-09-17 | 2006-01-20 | Актелион Фармасьютиклз Лтд. (Ch) | Производные 1-пиридин-4-илмочевины |
| JP2006525273A (ja) * | 2003-05-07 | 2006-11-09 | アクテリオン ファマシューティカルズ リミテッド | 新規なピペラジン誘導体 |
| US20070010516A1 (en) * | 2003-05-08 | 2007-01-11 | Hamed Aissaoui | Novel piperidine derivatives |
| BRPI0414777A (pt) * | 2003-09-26 | 2006-11-21 | Actelion Pharmaceuticals Ltd | compostos, composições farmacêuticas, uso de um ou mais compostos, e, método de tratar um paciente que sofre de um distúrbio |
| DE10358539A1 (de) * | 2003-12-15 | 2005-07-07 | Merck Patent Gmbh | Carbonsäureamidderivate |
| JP2008510755A (ja) | 2004-08-25 | 2008-04-10 | アクテリオン ファーマシューティカルズ リミテッド | ビシクロノネン誘導体 |
| MX2007004293A (es) * | 2004-10-12 | 2007-06-18 | Actelion Pharmaceuticals Ltd | 1[2-(4-bencil-4-hidroxi-piperidin-1-il)-etil]-3-(2-metil-quinolin -4-il)-urea como la sal de sulfato cristalina. |
| TW200630337A (en) * | 2004-10-14 | 2006-09-01 | Euro Celtique Sa | Piperidinyl compounds and the use thereof |
| US20070043104A1 (en) * | 2005-06-10 | 2007-02-22 | Luthman Ingrid K | UII-modulating compounds and their use |
| CN101384581B (zh) * | 2006-02-17 | 2013-09-18 | 弗·哈夫曼-拉罗切有限公司 | 作为5ht2/d3调节剂的苯甲酰基-哌啶衍生物 |
| EP1987019B1 (de) * | 2006-02-17 | 2012-11-28 | F. Hoffmann-La Roche AG | Benzoylpiperidinderivate als 5ht2/d3-modulatoren |
| WO2007110449A1 (en) | 2006-03-29 | 2007-10-04 | Euro-Celtique S.A. | Benzenesulfonamide compounds and their use |
| WO2007118853A1 (en) | 2006-04-13 | 2007-10-25 | Euro-Celtique S.A. | Benzenesulfonamide compounds and their use as blockers of calcium channels |
| TW200812963A (en) * | 2006-04-13 | 2008-03-16 | Euro Celtique Sa | Benzenesulfonamide compounds and the use thereof |
| EP2079693B1 (de) | 2006-10-31 | 2013-02-27 | F. Hoffmann-La Roche AG | Etherderivate als duale modulatoren der 5-ht2a- und d3-rezeptoren |
| US8399486B2 (en) | 2007-04-09 | 2013-03-19 | Purdue Pharma L.P. | Benzenesulfonyl compounds and the use thereof |
| JP2010527367A (ja) | 2007-05-15 | 2010-08-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ウロテンシンｉｉ受容体アンタゴニスト |
| KR20100020487A (ko) * | 2007-05-24 | 2010-02-22 | 와이어쓰 엘엘씨 | 히스타민-3 길항제로서 아자시클릴벤즈아미드 유도체 |
| ES2609258T3 (es) * | 2007-06-29 | 2017-04-19 | Pfizer Inc. | Derivados de bencimidazol |
| US8765736B2 (en) * | 2007-09-28 | 2014-07-01 | Purdue Pharma L.P. | Benzenesulfonamide compounds and the use thereof |
| US20090186567A1 (en) * | 2008-01-17 | 2009-07-23 | Xavier Orlhac | Abrasive Tool With Mosaic Grinding Face |
| CN102757447B (zh) * | 2011-07-05 | 2014-12-31 | 北京大学 | 一种尿素通道蛋白抑制剂及其制备方法与应用 |
| KR101468207B1 (ko) | 2013-02-14 | 2014-12-01 | 한국화학연구원 | 신규한 싸이에노[3,2-b]피리딜 우레아 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 유로텐신-Ⅱ 수용체 활성 관련 질환의 예방 또는 치료용 약학적 조성물 |
| KR101508214B1 (ko) * | 2013-03-07 | 2015-04-07 | 한국화학연구원 | 신규한 아졸-접합 피리딜 우레아 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 유로텐신-ⅱ 수용체 활성 관련 질환의 예방 또는 치료용 약학적 조성물 |
| FR3008619B1 (fr) * | 2013-07-16 | 2018-04-20 | Centre Hospitalier Universitaire De Rouen | Antagonistes, agonistes partiels et agonistes inverses du recepteur de l'urotensine ii pour leur utilisation dans la prevention des deficits neurologiques consecutifs a une hemorragie sous-arachnoidienne |
| AU2016210544B2 (en) * | 2015-01-23 | 2020-12-10 | Gvk Biosciences Private Limited | Inhibitors of TrkA kinase |
| CA2992054A1 (en) * | 2015-07-29 | 2017-02-02 | Laboratorios Del Dr. Esteve, S.A. | Amide derivatives having multimodal activity against pain |
| CN109306151B (zh) * | 2018-08-31 | 2020-08-14 | 大连理工大学 | 一种不含醚氧键型聚合物阴离子交换膜及其制备方法 |
| CN112830897B (zh) * | 2019-11-22 | 2022-09-09 | 石家庄以岭药业股份有限公司 | 含脲基苯并咪唑类衍生物及其制备方法和应用 |
| CN116139140A (zh) * | 2021-11-19 | 2023-05-23 | 中国医学科学院药物研究所 | 一种化合物在治疗糖皮质激素不良反应中的用途 |
| CN115677551A (zh) * | 2021-12-28 | 2023-02-03 | 武汉市振邦生物科技有限公司 | 一种2-氧代吡咯烷-3-甲酸乙酯的制备工艺 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI97540C (fi) | 1989-11-06 | 1997-01-10 | Sanofi Sa | Menetelmä terapeuttisesti käyttökelpoisten, aromaattisesti substituoitujen piperidiini- ja piperatsiinijohdannaisten valmistamiseksi |
| AUPP003197A0 (en) | 1997-09-03 | 1997-11-20 | Fujisawa Pharmaceutical Co., Ltd. | New heterocyclic compounds |
| WO2001009088A1 (en) | 1999-07-28 | 2001-02-08 | Kirin Beer Kabushiki Kaisha | Urea derivatives as inhibitors of ccr-3 receptor |
| EP1246619B1 (de) * | 1999-12-21 | 2004-10-20 | Smithkline Beecham Corporation | Urotensin-ii rezeptorantagonisten |
| JP2003518057A (ja) | 1999-12-21 | 2003-06-03 | スミスクライン・ビーチャム・コーポレイション | ウロテンシン−ｉｉ受容体アンタゴニスト |
| WO2001045711A1 (en) * | 1999-12-21 | 2001-06-28 | Smithkline Beecham Corporation | Urotensin-ii receptor antagonists |
| EP1262195A4 (de) | 2000-03-07 | 2003-05-21 | Takeda Chemical Industries Ltd | Vasoaktieve agentia |
| US20040063699A1 (en) | 2000-07-04 | 2004-04-01 | Naoki Tarui | Gpr14 antagonist |
| US20040039017A1 (en) | 2000-12-11 | 2004-02-26 | Dashyant Dhanak | Urotensin-II receptor antagonists |
| JP2004524295A (ja) | 2001-01-26 | 2004-08-12 | スミスクライン・ビーチャム・コーポレイション | ウロテンシン−ｉｉ受容体アンタゴニスト |
| JP2004525156A (ja) | 2001-03-29 | 2004-08-19 | スミスクライン・ビーチャム・コーポレイション | ピロリジンスルホンアミド |
| US20040142923A1 (en) | 2001-03-29 | 2004-07-22 | Dashyant Dhanak | Pyrrolidine sulfonamides |
| WO2002079155A1 (en) | 2001-03-29 | 2002-10-10 | Smithkline Beecham Corporation | Pyrrolidine sulfonamides |
| WO2002078707A1 (en) | 2001-03-29 | 2002-10-10 | Smithkline Beecham Corporation | Pyrrolidine sulfonamides |
-
2002
- 2002-12-02 DK DK02791749T patent/DK1499607T3/da active
- 2002-12-02 DE DE60207894T patent/DE60207894T2/de not_active Expired - Lifetime
- 2002-12-02 EP EP02791749A patent/EP1499607B1/de not_active Expired - Lifetime
- 2002-12-02 CA CA2473892A patent/CA2473892C/en not_active Expired - Fee Related
- 2002-12-02 US US10/501,054 patent/US7375227B2/en not_active Expired - Fee Related
- 2002-12-02 WO PCT/EP2002/013577 patent/WO2003048154A1/en not_active Ceased
- 2002-12-02 IL IL16285102A patent/IL162851A0/xx unknown
- 2002-12-02 AU AU2002358071A patent/AU2002358071B2/en not_active Ceased
- 2002-12-02 ES ES02791749T patent/ES2254772T3/es not_active Expired - Lifetime
- 2002-12-02 NZ NZ534046A patent/NZ534046A/en active Application Filing
- 2002-12-02 AT AT02791749T patent/ATE312090T1/de active
- 2002-12-02 SI SI200230270T patent/SI1499607T1/sl unknown
- 2002-12-02 HU HU0402184A patent/HUP0402184A2/hu unknown
- 2002-12-02 MX MXPA04006599A patent/MXPA04006599A/es active IP Right Grant
- 2002-12-02 CN CNB028277767A patent/CN100424082C/zh not_active Expired - Fee Related
-
2004
- 2004-07-05 NO NO20042844A patent/NO20042844L/no not_active Application Discontinuation
- 2004-07-05 ZA ZA2004/05348A patent/ZA200405348B/en unknown
-
2006
- 2006-03-07 CY CY20061100320T patent/CY1104993T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL162851A0 (en) | 2005-11-20 |
| ES2254772T3 (es) | 2006-06-16 |
| CA2473892A1 (en) | 2003-06-12 |
| MXPA04006599A (es) | 2004-12-07 |
| US20050043535A1 (en) | 2005-02-24 |
| ZA200405348B (en) | 2005-12-28 |
| NZ534046A (en) | 2006-02-24 |
| DE60207894T2 (de) | 2006-07-20 |
| AU2002358071A1 (en) | 2003-06-17 |
| DE60207894D1 (en) | 2006-01-12 |
| CN100424082C (zh) | 2008-10-08 |
| SI1499607T1 (sl) | 2006-06-30 |
| CY1104993T1 (el) | 2010-03-03 |
| CA2473892C (en) | 2010-09-21 |
| HUP0402184A2 (hu) | 2005-02-28 |
| EP1499607A1 (de) | 2005-01-26 |
| AU2002358071B2 (en) | 2008-06-12 |
| EP1499607B1 (de) | 2005-12-07 |
| DK1499607T3 (da) | 2006-04-18 |
| US7375227B2 (en) | 2008-05-20 |
| CN1617869A (zh) | 2005-05-18 |
| WO2003048154A1 (en) | 2003-06-12 |
| ATE312090T1 (de) | 2005-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20042844L (no) | 4-(piperidyl- og pyrrolidyl-alkyl-ureido)-kinoliner som uprotensin II reseptor-antagonister | |
| NO20034230D0 (no) | 1,2,3,4-tetrahydroisokinolin-derivater som urotensin II reseptor-antagonister | |
| NO20051102L (no) | Sulfonylamino-eddiksyre-derivater | |
| ATE286500T1 (de) | 1,2,3,4-tetrahydroisochinolin-derivate | |
| NO20032905D0 (no) | Nye benzodiazepiner og beslektede heterocykliske derivater som er anvendelige som orexinreseptorantagonister | |
| MXPA03004780A (es) | Nuevas sulfamidas. | |
| MXPA05010137A (es) | Derivados de tetrahidroisoquinolil acetamida para usarse como antagonistas del receptor de orexina. | |
| WO2004026836A8 (en) | 1-pyridin-4-yl-urea derivatives | |
| ATE383345T1 (de) | Quinoxalin-3-on-verdindungen als orexin-rezeptor antagonisten. | |
| MXPA04001252A (es) | Nuevos heterociclos benzo-fusionados como antagonistas de endotelina. | |
| WO2005030209A8 (en) | Pyridine derivatives and use thereof as urotensin ii antagonists | |
| DE60326263D1 (de) | Pyrimidin-sulfonamide und ihre verwendung als endothelin-rezeptor-antagonisten | |
| WO2002024665A8 (en) | Arylalkane-sulfonamides having endothelin-antagonist activity | |
| DK1307445T3 (da) | Benzofuranderivater og deres anvendelse som antibakterielle midler | |
| MXPA03000430A (es) | Nuevas arileteno-sulfonamidas. | |
| NO20022971L (no) | Butyndiol-derivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |